Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Type I IFN-related NETosis in ataxia telangiectasia and Artemis deficiency.

Gul E, Sayar EH, Gungor B, Eroglu FK, Surucu N, Keles S, Guner SN, Findik S, Alpdundar E, Ayanoglu IC, Kayaoglu B, Geckin BN, Sanli HA, Kahraman T, Yakicier C, Muftuoglu M, Oguz B, Cagdas Ayvaz DN, Gursel I, Ozen S, Reisli I, Gursel M.

J Allergy Clin Immunol. 2018 Jul;142(1):246-257. doi: 10.1016/j.jaci.2017.10.030. Epub 2017 Nov 16.

PMID:
29155101
2.

Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development.

Bayyurt B, Tincer G, Almacioglu K, Alpdundar E, Gursel M, Gursel I.

J Control Release. 2017 Feb 10;247:134-144. doi: 10.1016/j.jconrel.2017.01.004. Epub 2017 Jan 7.

PMID:
28069554
3.

Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.

Yildiz S, Alpdundar E, Gungor B, Kahraman T, Bayyurt B, Gursel I, Gursel M.

Eur J Immunol. 2015 Apr;45(4):1170-9. doi: 10.1002/eji.201445133. Epub 2015 Feb 4.

4.

CpG ODN nanorings induce IFN╬▒ from plasmacytoid dendritic cells and demonstrate potent vaccine adjuvant activity.

Gungor B, Yagci FC, Tincer G, Bayyurt B, Alpdundar E, Yildiz S, Ozcan M, Gursel I, Gursel M.

Sci Transl Med. 2014 May 7;6(235):235ra61. doi: 10.1126/scitranslmed.3007909.

Supplemental Content

Loading ...
Support Center